Shelton Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,300
| Closed | -$203K | – | 850 |
|
|
2019
Q2 | $203K | Buy |
7,300
+7,049
| +2,808% | +$196K | 0.01% | 762 |
|
|
2019
Q1 | $7.57K | Sell |
251
-7,318
| -97% | -$221K | 0.03% | 476 |
|
|
2018
Q4 | $220K | Buy |
7,569
+555
| +8% | +$16.1K | 0.02% | 650 |
|
|
2018
Q3 | $323K | Buy |
7,014
+438
| +7% | +$20.2K | 0.02% | 545 |
|
|
2018
Q2 | $246K | Buy |
+6,576
| New | +$246K | 0.02% | 682 |
|
|
2018
Q1 | – | Sell |
-6,576
| Closed | -$226K | – | 871 |
|
|
2017
Q4 | $226K | Hold |
6,576
| – | – | 0.01% | 750 |
|
|
2017
Q3 | $238K | Buy |
+6,576
| New | +$238K | 0.02% | 693 |
|